NeOnc Technologies Announces Strategic Partnership and IP Acquisition

SEC Filing 8-K (0001829126-25-005708)

NeOnc Technologies Holdings, Inc. has entered into a definitive agreement with Quazar Investment for a $50 million strategic partnership, which includes the acquisition of 1.4 million shares of NeOnc at $25 per share. The partnership aims to accelerate global expansion and scientific innovation, with $15 million earmarked for Phase 2B clinical trials and infrastructure buildout in the UAE and MENA region. Additionally, NeOnc has signed a definitive agreement to acquire AI, 3D, and Quantum Modeling IP Portfolio from Dr. Ishwar K. Puri, appointing him to the Board of Directors. The transaction is valued at $3.5 million, comprising $500,000 in cash and $3 million in NeOnc common stock. These developments mark significant steps in NeOnc's global therapeutic footprint and innovation in brain cancer treatments.